Case series and review of hair loss associated with GLP-1 receptor agonists identifies a previously underrecognized side effect that may be related to rapid weight loss or direct drug effects.
Key findingCase series and review of hair loss associated with GLP-1 receptor agonists identifies a previously
What the researchers found
Case series and review of hair loss associated with GLP-1 receptor agonists identifies a previously underrecognized side effect that may be related to rapid weight loss or direct drug effects.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
Systematic review of FAERS dermatological adverse events and clinical literature on GLP-1 RA-associated hair loss.
How the study worked
In publication.
Who was studied
GLP-1 drug users who reported hair loss across FAERS and clinical literature
What this study cannot tell us
In publication.
How to read the evidence
Based on study design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide therapeutic knowledge.
Questions still open
- Long-term implications?
- Comparison to evidence?
- Next research?
Common questions
What does this mean?
How reliable?
Read the original research
Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review.
Cureus, 17(9), e92454
Citation
Alsuwailem, Omar A; Alanazi, Rawan; Almutairi, Hessa M; Asiree, Rayan H; Almutairi, Wasan; Almutairi, Taghreed M; Zamandar, Alia; Alkhames, Saleh. (2025). Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review.. Cureus, 17(9), e92454. https://doi.org/10.7759/cureus.92454